Bupropion SR
ApprovedTerminated 0 watching 0 views this week🔥 Hot
85
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Tobacco Use Disorder
Conditions
Tobacco Use Disorder
Trial Timeline
Mar 1, 2005 → Mar 1, 2006
NCT ID
NCT00119210About Bupropion SR
Bupropion SR is a approved stage product being developed by Johnson & Johnson for Tobacco Use Disorder. The current trial status is terminated. This product is registered under clinical trial identifier NCT00119210. Target conditions include Tobacco Use Disorder.
Hype Score Breakdown
Clinical
30
Activity
20
Company
10
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00119210 | Approved | Terminated |
Competing Products
20 competing products in Tobacco Use Disorder